Niraparib, Abiraterone Acetate and Prednisone for mHSPC With Deleterious Homologous Recombination Repair Alterations

Clinical trial NCT06392841 · WITHDRAWN

Trial details

NCT number: NCT06392841
Sponsor: Qian Qin
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)Deleterious HRR Gene Mutation BRCA1 Gene Mutation BRCA2 Gene Mutation BRIP1 Gene Mutation CHEK2 Gene Mutation FANCA Gene Mutation PALB2 Gene Mutation RAD51B Gene Mutation RAD54L Gene Mutation

Start date: 2025-10-01
Primary completion: 2028-01-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.